234 related articles for article (PubMed ID: 7720827)
1. Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms.
Lindner MD; Winn SR; Baetge EE; Hammang JP; Gentile FT; Doherty E; McDermott PE; Frydel B; Ullman MD; Schallert T
Exp Neurol; 1995 Mar; 132(1):62-76. PubMed ID: 7720827
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease.
Shingo T; Date I; Yoshida H; Ohmoto T
J Neurosci Res; 2002 Sep; 69(6):946-54. PubMed ID: 12205688
[TBL] [Abstract][Full Text] [Related]
3. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine.
Tseng JL; Baetge EE; Zurn AD; Aebischer P
J Neurosci; 1997 Jan; 17(1):325-33. PubMed ID: 8987758
[TBL] [Abstract][Full Text] [Related]
4. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats.
Grandoso L; Ponce S; Manuel I; Arrúe A; Ruiz-Ortega JA; Ulibarri I; Orive G; Hernández RM; Rodríguez A; Rodríguez-Puertas R; Zumárraga M; Linazasoro G; Pedraz JL; Ugedo L
Int J Pharm; 2007 Oct; 343(1-2):69-78. PubMed ID: 17583454
[TBL] [Abstract][Full Text] [Related]
6. Continued presence of intrastriatal but not intraventricular polymer-encapsulated PC12 cells is required for alleviation of behavioral deficits in Parkinsonian rodents.
Emerich DF; Winn SR; Lindner MD
Cell Transplant; 1996; 5(5):589-96. PubMed ID: 8889217
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of reaction of primate brain to grafted PC12 cells.
Yoshida H; Date I; Shingo T; Fujiwara K; Miyoshi Y; Furuta T; Ohmoto T
Cell Transplant; 1999; 8(4):427-30. PubMed ID: 10478724
[TBL] [Abstract][Full Text] [Related]
8. Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats.
Lindner MD; Plone MA; Mullins TD; Winn SR; Chandonait SE; Stott JA; Blaney TJ; Sherman SS; Emerich DF
Exp Neurol; 1997 May; 145(1):130-40. PubMed ID: 9184116
[TBL] [Abstract][Full Text] [Related]
9. Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease.
Yasuhara T; Shingo T; Muraoka K; Kobayashi K; Takeuchi A; Yano A; Wenji Y; Kameda M; Matsui T; Miyoshi Y; Date I
J Neurosurg; 2005 Jan; 102(1):80-9. PubMed ID: 15658100
[TBL] [Abstract][Full Text] [Related]
10. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.
Sautter J; Tseng JL; Braguglia D; Aebischer P; Spenger C; Seiler RW; Widmer HR; Zurn AD
Exp Neurol; 1998 Jan; 149(1):230-6. PubMed ID: 9454632
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic transplantation of a dopamine-producing capsule into the striatum for treatment of Parkinson disease: a preclinical primate study.
Yoshida H; Date I; Shingo T; Fujiwara K; Kobayashi K; Miyoshi Y; Ohmoto T
J Neurosurg; 2003 Apr; 98(4):874-81. PubMed ID: 12691415
[TBL] [Abstract][Full Text] [Related]
12. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
13. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.
Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I
Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923
[TBL] [Abstract][Full Text] [Related]
14. Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo.
Sullivan AM; Opacka-Juffry J; Blunt SB
Eur J Neurosci; 1998 Jan; 10(1):57-63. PubMed ID: 9753113
[TBL] [Abstract][Full Text] [Related]
15. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
[TBL] [Abstract][Full Text] [Related]
16. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
[TBL] [Abstract][Full Text] [Related]
17. Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts.
Emerich DF; Plone M; Francis J; Frydel BR; Winn SR; Lindner MD
Brain Res; 1996 Oct; 736(1-2):99-110. PubMed ID: 8930314
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Transplantation of Fetal Ventral Mesencephalic Tissue and Encapsulated Genetically Modified Cells Releasing GDNF in a Hemi-Parkinsonian Rat Model of Parkinson's Disease.
Perez-Bouza A; Di Santo S; Seiler S; Meyer M; Andereggen L; Huber A; Guzman R; Widmer HR
Cell Transplant; 2017 Sep; 26(9):1572-1581. PubMed ID: 29113462
[TBL] [Abstract][Full Text] [Related]
19. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
Espejo M; Cutillas B; Arenas TE; Ambrosio S
Cell Transplant; 2000; 9(1):45-53. PubMed ID: 10784066
[TBL] [Abstract][Full Text] [Related]
20. Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease.
Sajadi A; Bensadoun JC; Schneider BL; Lo Bianco C; Aebischer P
Neurobiol Dis; 2006 Apr; 22(1):119-29. PubMed ID: 16300956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
